| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | A. Minagar | |
| D. Pelletier | |||
| E. Frohman | |||
| I. Pirko | |||
| M. A. Sahraian | |||
| M. H. Barnett | |||
| R. H. B. Benedict | |||
| R. Zivadinov | |||
| P2860 | cites work | Gray matter involvement in multiple sclerosis | Q28290321 |
| Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord | Q28295737 | ||
| Thalamic neurodegeneration in relapsing-remitting multiple sclerosis | Q30806071 | ||
| The puzzle of multiple sclerosis: gray matter finds its place. | Q33352371 | ||
| Thalamic damage and long-term progression of disability in multiple sclerosis. | Q33665968 | ||
| Recent developments in imaging of multiple sclerosis | Q33945270 | ||
| Gray matter imaging in multiple sclerosis: what have we learned? | Q34094761 | ||
| Meningeal and cortical grey matter pathology in multiple sclerosis | Q34187428 | ||
| Transient movement disorders and multiple sclerosis | Q78632391 | ||
| Thalamic atrophy and cognition in multiple sclerosis | Q81310729 | ||
| The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions | Q81485093 | ||
| MRI correlates of cognitive impairment in childhood-onset multiple sclerosis | Q84012558 | ||
| The predictive value of gray matter atrophy in clinically isolated syndromes | Q84197250 | ||
| Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis. | Q34582216 | ||
| Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. | Q34986741 | ||
| Minimal neuropsychological assessment of MS patients: a consensus approach | Q35073778 | ||
| Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis | Q35481531 | ||
| Inflammatory cortical demyelination in early multiple sclerosis | Q35764685 | ||
| Cortical lesions and brain atrophy in MS. | Q36127222 | ||
| Regional grey matter atrophy in clinically isolated syndromes at presentation | Q36787309 | ||
| Physiopathology of fatigue in multiple sclerosis | Q37238927 | ||
| Damage to the optic radiation in multiple sclerosis is associated with retinal injury and visual disability | Q37443546 | ||
| Thalamic involvement and its impact on clinical disability in patients with multiple sclerosis: a diffusion tensor imaging study at 3T. | Q39987214 | ||
| Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients | Q41826954 | ||
| T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis | Q42454590 | ||
| Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis | Q43806089 | ||
| The relationship between diffuse axonal damage and fatigue in multiple sclerosis | Q44766912 | ||
| Three-dimensional proton spectroscopy of deep gray matter nuclei in relapsing-remitting MS. | Q44975182 | ||
| Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. | Q45191165 | ||
| Connecting white matter injury and thalamic atrophy in clinically isolated syndromes. | Q46023385 | ||
| Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study | Q46309628 | ||
| Clinical and conventional MRI predictors of disability and brain atrophy accumulation in RRMS. A large scale, short-term follow-up study. | Q46515719 | ||
| Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis | Q47203630 | ||
| Reduced head and brain size for age and disproportionately smaller thalami in child-onset MS. | Q47334177 | ||
| Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing—remitting multiple sclerosis | Q48106940 | ||
| Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. | Q48200750 | ||
| Subpial demyelination in the cerebral cortex of multiple sclerosis patients | Q48233815 | ||
| Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosis | Q48236822 | ||
| Cortical atrophy is relevant in multiple sclerosis at clinical onset. | Q48241189 | ||
| Expression of PACAP and glutamate transporter proteins in satellite oligodendrocytes of the human CNS. | Q48250132 | ||
| Neocortical neuronal, synaptic, and glial loss in multiple sclerosis | Q48413281 | ||
| Thalamic neurodegeneration in multiple sclerosis | Q48459257 | ||
| Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis | Q48553203 | ||
| Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy | Q48591960 | ||
| Paroxysmal dystonia with thalamic lesion in multiple sclerosis | Q48649226 | ||
| Postmortem verification of MS cortical lesion detection with 3D DIR. | Q48728637 | ||
| Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions | Q48791086 | ||
| Thalamic volume predicts performance on tests of cognitive speed and decreases in healthy aging. A magnetic resonance imaging-based volumetric analysis | Q48888059 | ||
| Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study | Q48960941 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| Regional brain atrophy in children with multiple sclerosis. | Q51590429 | ||
| Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. | Q52093524 | ||
| Fatigue in multiple sclerosis persists over time | Q57601977 | ||
| Thalamic Damage Predicts the Evolution of Primary-Progressive Multiple Sclerosis at 5 Years | Q57911768 | ||
| A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes | Q57911812 | ||
| Evidence of thalamic gray matter loss in pediatric multiple sclerosis | Q57911816 | ||
| Grey Matter Pathology in Multiple Sclerosis | Q61478750 | ||
| Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes | Q61861975 | ||
| Effects of age and sex on volumes of the thalamus, pons, and cortex | Q75353724 | ||
| T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study | Q77486197 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple sclerosis | Q8277 |
| P304 | page(s) | 210-9 | |
| P577 | publication date | 2013-01-08 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects | |
| P478 | volume | 80 |
| Q35914600 | A New Approach for Deep Gray Matter Analysis Using Partial-Volume Estimation |
| Q48901292 | A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients |
| Q57911626 | Abnormal functional connectivity of thalamic sub-regions contributes to fatigue in multiple sclerosis |
| Q98463732 | Advanced MRI features in relapsing multiple sclerosis patients with and without CSF oligoclonal IgG bands |
| Q89957895 | Alterations in functional connectivity are associated with white matter lesions and information processing efficiency in multiple sclerosis |
| Q47552358 | Altered Functional Connectivity of the Default Mode Network in Patients With Schizo-obsessive Comorbidity: A Comparison Between Schizophrenia and Obsessive-compulsive Disorder. |
| Q36865891 | Altered Gray Matter Volume and White Matter Integrity in College Students with Mobile Phone Dependence |
| Q93089325 | Application of Graph Theory for Identifying Connectivity Patterns in Human Brain Networks: A Systematic Review |
| Q64073642 | Assessment and Impact of Cognitive Impairment in Multiple Sclerosis: An Overview |
| Q91137196 | Association between pathological and MRI findings in multiple sclerosis |
| Q21558427 | Associations between Proprioceptive Neural Pathway Structural Connectivity and Balance in People with Multiple Sclerosis |
| Q48359324 | Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume. |
| Q90633167 | Autophagy lipidation machinery regulates axonal microtubule dynamics but is dispensable for survival of mammalian neurons |
| Q46049532 | Bithalamic Inflammation in Relapsing-Remitting Multiple Sclerosis |
| Q57474921 | Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study |
| Q48660868 | Brain atrophy measurements should be used to guide therapy monitoring in MS - YES. |
| Q30889903 | Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis |
| Q93164184 | Clinical predictivity of thalamic sub-regional connectivity in clinically isolated syndrome: a 7-year study |
| Q35997017 | Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine |
| Q41357899 | Co-occurrence of multiple sclerosis and Parkinson disease |
| Q49972473 | Cognition in multiple sclerosis. |
| Q90639118 | Cognitive Impairment and Brain Reorganization in MS: Underlying Mechanisms and the Role of Neurorehabilitation |
| Q35529255 | Cognitive impairment in multiple sclerosis: clinical, radiologic and pathologic insights. |
| Q47882340 | Cognitive reserve, cognition, and regional brain damage in MS: A 2 -year longitudinal study. |
| Q52141693 | Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis. |
| Q48230229 | Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study |
| Q42946025 | Contingent negative variation is associated with cognitive dysfunction and secondary progressive disease course in multiple sclerosis |
| Q38942618 | Cumulative evidence for MS as a neural network disconnection syndrome consistent with cognitive impairment mechanisms and the confounding role of fatigue and depression-outlook from the Fourth Nordic MS symposium |
| Q39069235 | Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis |
| Q37419819 | Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model |
| Q48735623 | Deep grey matter involvement in multiple sclerosis: key player or bystander? |
| Q91897392 | Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in |
| Q90679880 | Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study |
| Q89930516 | Disrupted principal network organisation in multiple sclerosis relates to disability |
| Q57821321 | Disruption of neurite morphology parallels MS progression |
| Q36247257 | Early and Degressive Putamen Atrophy in Multiple Sclerosis. |
| Q48875299 | Early silent microstructural degeneration and atrophy of the thalamocortical network in multiple sclerosis |
| Q38630407 | Effect of teriflunomide on cortex-basal ganglia-thalamus (CxBGTh) circuit glutamatergic dysregulation in the Theiler's Murine Encephalomyelitis Virus mouse model of multiple sclerosis |
| Q55248978 | Effects of Rhythmic Auditory Cueing in Gait Rehabilitation for Multiple Sclerosis: A Mini Systematic Review and Meta-Analysis. |
| Q38159892 | Endocrine autoimmune diseases and female infertility. |
| Q42269985 | Evaluating the effect of multiple sclerosis lesions on automatic brain structure segmentation. |
| Q35984184 | Evidencing different neurochemical profiles between thalamic nuclei using high resolution 2D-PRESS semi-LASER (1)H-MRSI at 7 T. |
| Q46466612 | Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years |
| Q55282589 | Explaining the heterogeneity of functional connectivity findings in multiple sclerosis: An empirically informed modeling study. |
| Q48493566 | Functional brain networks: linking thalamic atrophy to clinical disability in multiple sclerosis, a multimodal fMRI and MEG study |
| Q41839603 | Functional cortical changes in relapsing-remitting multiple sclerosis at amplitude configuration: a resting-state fMRI study |
| Q48262890 | Functional network connectivity abnormalities in multiple sclerosis: Correlations with disability and cognitive impairment. |
| Q45841514 | Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest |
| Q30768942 | Gray matters in multiple sclerosis: cognitive impairment and structural MRI. |
| Q44642567 | Grey matter damage in progressive multiple sclerosis versus amyotrophic lateral sclerosis: a voxel-based morphometry MRI study. |
| Q48659658 | Hemispheric asymmetry measured by texture analysis and diffusion tensor imaging in two multiple sclerosis subtypes |
| Q46045619 | Heterogeneous pathological processes account for thalamic degeneration in multiple sclerosis: Insights from 7 T imaging. |
| Q91760777 | Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS |
| Q49664670 | Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis |
| Q89434252 | Impact of Focal White Matter Damage on Localized Subcortical Gray Matter Atrophy in Multiple Sclerosis: A 5-Year Study |
| Q38736551 | Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis |
| Q45355943 | Impaired functional integration in multiple sclerosis: a graph theory study |
| Q38377029 | Improved cognitive outcomes in patients with relapsing-remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study |
| Q52149416 | Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later. |
| Q89982835 | Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging |
| Q31152127 | Inversion recovery ultrashort echo time magnetic resonance imaging: A method for simultaneous direct detection of myelin and high signal demonstration of iron deposition in the brain - A feasibility study |
| Q92217725 | Longitudinal change in regional brain volumes with exposure to repetitive head impacts |
| Q34431806 | MRI correlates of disability progression in patients with CIS over 48 months |
| Q30981999 | MRI in the Diagnosis and Monitoring of Multiple Sclerosis: An Update |
| Q36400004 | MRI in the assessment and monitoring of multiple sclerosis: an update on best practice |
| Q47989756 | Mapping of thalamic magnetic susceptibility in multiple sclerosis indicates decreasing iron with disease duration: A proposed mechanistic relationship between inflammation and oligodendrocyte vitality |
| Q30926815 | Measuring Gray Matter and White Matter Damage in MS: Why This is Not Enough |
| Q42426175 | Metabolic voxel-based analysis of the complete human brain using fast 3D-MRSI: Proof of concept in multiple sclerosis |
| Q91210808 | Multiple sclerosis and cognition: synaptic failure and network dysfunction |
| Q50559760 | Multiple sclerosis and risk of Parkinson's disease: a Danish nationwide cohort study. |
| Q34607681 | Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron |
| Q47804784 | Neuropsychology of Multiple Sclerosis: Looking Back and Moving Forward. |
| Q31166509 | New rapid, accurate T2 quantification detects pathology in normal-appearing brain regions of relapsing-remitting MS patients. |
| Q58712339 | Occulomotor Neural Integrator Dysfunction in Multiple Sclerosis: Insights From Neuroimaging |
| Q34771225 | Onset of multiple sclerosis before adulthood leads to failure of age-expected brain growth |
| Q28265269 | Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis |
| Q35221948 | Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in multiple sclerosis |
| Q55362467 | Progression of regional grey matter atrophy in multiple sclerosis. |
| Q64262818 | Quantitative vibratory sensation measurement is related to sensory cortical thickness in MS |
| Q92071009 | Relapsing-Remitting Multiple Sclerosis Is Associated With Regional Brain Activity Deficits in Motor- and Cognitive-Related Brain Areas |
| Q35899621 | Repeated head trauma is associated with smaller thalamic volumes and slower processing speed: the Professional Fighters' Brain Health Study |
| Q59808694 | Resting-state MEG measurement of functional activation as a biomarker for cognitive decline in MS |
| Q38790916 | Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study. |
| Q48402350 | Role of thalamic diffusion for disease differentiation between multiple sclerosis and ischemic cerebral small vessel disease |
| Q38737202 | Spring cleaning: time to rethink imaging research lines in MS? |
| Q36957820 | Statistical estimation of T1 relaxation times using conventional magnetic resonance imaging. |
| Q48020669 | Structural connectivity-defined thalamic subregions have different functional connectivity abnormalities in multiple sclerosis patients: Implications for clinical correlations |
| Q44486220 | Subcortical deep gray matter pathology in patients with multiple sclerosis is associated with white matter lesion burden and atrophy but not with cortical atrophy: a diffusion tensor MRI study. |
| Q37504560 | Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis |
| Q50067249 | Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout disease. |
| Q89162210 | Thalamic white matter in multiple sclerosis: A combined diffusion-tensor imaging and quantitative susceptibility mapping study |
| Q35672483 | Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis |
| Q39662507 | Thalamocortical-auditory network alterations following cuprizone-induced demyelination |
| Q48127262 | Thalamus Degeneration and Inflammation in Two Distinct Multiple Sclerosis Animal Models |
| Q30871067 | Thalamus pathology in multiple sclerosis: from biology to clinical application. |
| Q88992640 | Thalamus volume change and cognitive impairment in early relapsing-remitting multiple sclerosis patients |
| Q38460984 | The thalamus as a putative biomarker in neurodegenerative disorders. |
| Q39131745 | The yearly rate of Relative Thalamic Atrophy (yrRTA): a simple 2D/3D method for estimating deep gray matter atrophy in Multiple Sclerosis |
| Q48507792 | Transbulbar B-Mode Sonography in Multiple Sclerosis: Clinical and Biological Relevance. |
| Q37590821 | Visualization of intra-thalamic nuclei with optimized white-matter-nulled MPRAGE at 7T. |
| Q97067402 | Visualizing the Central Nervous System: Imaging Tools for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders |
| Q49083945 | Whole brain functional connectivity in clinically isolated syndrome without conventional brain MRI lesions |
| Q48677791 | Whole-brain diffusion tensor imaging in correlation to visual-evoked potentials in multiple sclerosis: a tract-based spatial statistics analysis |
Search more.